| 1 |
任成山，王关嵩，钱桂生. 慢性阻塞性肺疾病的成因及其治疗的困惑与希望[J/CD]. 中华肺部疾病杂志(电子版), 2019, 12(2): 127-141.
|
| 2 |
Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global bueden of disease study[J]. Lancet，1997, 348(9064): 1498-1504.
|
| 3 |
Omar A, Ganapathy SS, Anuar MFM, et al. Cause-specific mortality estimates for Malaysia in 2013: results from a national sample verification study using medical record review and verbal autopsy[J]. BMC Public Health, 2019, 19(1): 110.
|
| 4 |
Lopez AD, Shibuya K, Rao C, et al. Chronic obstructive pulmonary disease: current burden and future projections[J]. Eur Respir, 2006, 27: 397-412.
|
| 5 |
Lakiang T, Nair NS, Ramaswamy A, et al. Economic impact of chronic obstructive pulmonary disease: A cross-sectional study at teaching hospital in South India[J]. J Family Med Prim Care, 2018, 7(5): 1002-1006.
|
| 6 |
Wang Xishuai, Wang Zhiqing, Tang Donghui. Aerobic exercise alleviates inflammation, oxidative Stress, and Apoptosis in Mice with Chronic Obstructive Pulmonary Disease[J]. Int J Chron Obstruct Pulmon Dis, 2021, 16: 1369-1379.
|
| 7 |
Qu Jiao, Yue Li, Gao Jian, et al. Perspectives on wnt signal pathway in the pathogenesis and therapeutics of chronic obstructive pulmonary disease[J]. J Pharmacol Exp Ther, 2019, 369: 473-480.
|
| 8 |
El Kharbili Manale, Aviszus Katja, Sasse Sarah K, et al. Macrophage programming is regulated by a cooperative interaction between fatty acid binding protein 5 and peroxisome proliferator-activated receptor γ[J]. FASEB J, 2022, 36: e22300.
|
| 9 |
Faner Rosa, Sobradillo Patricia, Noguera Aina, et al. The inflammasome pathway in stable COPD and acute exacerbations[J]. ERJ Open Res, 2016, 2(3): 00002-2016.
|
| 10 |
De Nardo D, De Nardo CM, Latz E. New insights into mechanisms controlling the NLRP3 inflammasome and its role in lung disease[J]. Am J Pathol, 2014, 184(1): 42-54.
|
| 11 |
Rovina N, Koutsoukou A, Koulouris NG. Inflammation and immune response in COPD: where do we stand[J]. Mediators Inflamm, 2013: 413735.
|
| 12 |
Pauwels NS, Bracke KR, Dupont LL, et al. Role of IL-1α and the Nlrp3/caspase-1/IL-1β axis in cigarette smoke-induced pulmonary inflammation and COPD[J]. Eur Respir J, 2011, 38: 1019-1028.
|
| 13 |
Li C, Zhihong H, Wenlong L, et al. The nucleotide-binding oligomerization domain-like receptor family pyrin domain-containing 3 inflammasome regulates bronchial epithelial cell injury and proapoptosis after exposure to biomass fuel smoke[J]. Am J Respir Cell Mol Biol, 2016, 55(6): 815-824.
|
| 14 |
Peng Z, Zhang W, Qiao J, et al. Melatonin attenuates airway inflammation via SIRT1 dependent inhibition of NLRP3 inflammasome and IL-1β in rats with COPD[J]. Int Immunopharmacol, 2018, 62: 23-28.
|
| 15 |
Liudmila Andreeva, Liron David, Shaun Rawson, et al. NLRP3 cages revealed by full-length mouse NLRP3 structure control pathway activation.[J]. Cell, 2021, 184: 6299-6312.
|
| 16 |
Lin Xin, Zhu Yong, Le Guohui, Tetramethylpyrazine Alleviates Tight Junction Disruption of Bronchial Mucosal Epithelial Cells Caused by Interleukin-17 via Inhibiting Nuclear Factor-κB-p65/Tumor Necrosis Factor-α Signaling Pathway.[J]. J Interferon Cytokine Res, 2021, 41: 415-424.
|
| 17 |
Malaviya Rama, Laskin Jeffrey D, Laskin Debra L, Anti-TNFα therapy in inflammatory lung diseases.[J]. Pharmacol Ther, 2017, 180: 90-98.
|
| 18 |
Niu Jiani, Cederstrand Annika J, Eddinger Geoffrey A, et al. Trimer-to-Monomer Disruption Mechanism for a Potent, Protease-Resistant Antagonist of Tumor Necrosis Factor-α Signaling[J]. J Am Chem Soc, 2022, undefined: undefined.
|
| 19 |
Jang Dan-In, Lee A-Hyeon, Shin Hye-Yoon, et al. The Role of Tumor Necrosis Factor Alpha (TNF-α) in Autoimmune Disease and Current TNF-α Inhibitors in Therapeutics.[J]. Int J Mol Sci, 2021, 22: undefined.
|
| 20 |
Gao Wei, Gao Lianjun, Yang Feng, et al. Circulating JNK pathway-associated phosphatase: A novel biomarker correlates with Th17 cells, acute exacerbation risk, and severity in chronic obstructive pulmonary disease patients.[J]. J Clin Lab Anal, 2022, 36: e24153.
|
| 21 |
Aggarwal BB. Signalling pathways of the TNF superfamily: a double-edged sword[J]. Nat Rev Immunol, 2009, 9(4): 271-285.
|
| 22 |
Irena Mazur-Bialy Agnieszka, Ewa Pochec, HMGB1 Inhibition During Zymosan-Induced Inflammation: The Potential Therapeutic Action of Riboflavin.[J]. Arch Immunol Ther Exp (Warsz), 2016, 64: 171-176.
|
| 23 |
Dong Yuanji, Ming Bingxia, Dong Lingli, The Role of HMGB1 in Rheumatic Diseases.[J]. Front Immunol, 2022, 13: 815257.
|
| 24 |
Li M, Guo L, Wang H, et al. RAGE-ligands axis: A new 'driving force' for cigarette smoke-induced airway inflammation in COPD[J]. Respirology, 2015, 20(6): 998-999.
|
| 25 |
Zhang Y, Li S, Wang G, et al. Changes of HMGB1 and sRAGE during the recovery of COPD exacerbation[J]. Thorac Dis, 2014, 6: 734-741.
|
| 26 |
Wang Huijie, Zhong Yonghong, Li Na, et al. Transcriptomic analysis and validation reveal the pathogenesis and a novel biomarker of acute exacerbation of chronic obstructive pulmonary disease.[J]. Respir Res, 2022, 23: 27.
|
| 27 |
Ilana Levy, Yotam Elimeleh, Sagi Gavrieli, et al. Treatment of acute exacerbations of chronic obstructive pulmonary disease with acupuncture during hospitalization: a three-arm double-blinded randomized sham-controlled trial.[J]. Acupunct Med, 2022, undefined: 9645284221086293.
|
| 28 |
Shi Lin, Zhu Bijun, Xu Menglin, et al. Selection of AECOPD-specific immunomodulatory biomarkers by integrating genomics and proteomics with clinical informatics.[J]. Cell Biol Toxicol, 2018, 34: 109-123.
|
| 29 |
Li Xiaolong, Wu Zhen, Xue Mingyue, et al. Smoking status affects clinical characteristics and disease course of acute exacerbation of chronic obstructive pulmonary disease: A prospectively observational study.[J]. Chron Respir Dis, 2020, 17: 1479973120916184.
|
| 30 |
Kang MJ, Choi JM, Kim BH, et al. IL-18 induces emphysema and airway and vascular remodeling via IFN-γ，IL-17A, and IL-13[J]. Am J Respir Crit Care Med, 2012, 185(11): 1205-1217.
|